|
| Sales 2022 |
6 306 M
–
–
|
| Net income 2022 |
902 M
–
–
|
| Net cash 2022 |
2 273 M
–
–
|
| P/E ratio 2022 |
23,1x |
| Yield 2022 |
2,20% |
|
| Capitalization |
20 243 M
20 243 M
–
|
| EV / Sales 2022 |
2,85x |
| EV / Sales 2023 |
2,62x |
| Nbr of Employees |
11 000 |
| Free-Float |
99,8% |
|
|
|
Duration : Auto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax.
Period : DayWeek
|
|
|
|
Technical analysis trends NETAPP, INC.
|
Short Term |
Mid-Term |
Long Term |
| Trends |
Neutral |
Neutral |
Neutral |
Income Statement Evolution
Please enable JavaScript in your browser’s settings to use dynamic charts.
|
Sell
Buy
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
23 |
| Last Close Price |
91,07 $ |
| Average target price |
99,95 $ |
| Spread / Average Target |
9,75% |
Please enable JavaScript in your browser’s settings to use dynamic charts.
|
Source: https://www.marketscreener.com/quote/stock/NETAPP-INC-4889/news/NetApp-Managing-the-health-of-at-risk-populations-begins-with-data-intelligence-39512677/
